This Week in Cell

A Memorial Sloan Kettering-led team tracks tumor genomic changes in individuals with advanced melanoma receiving the anti-PD-1 immune checkpoint treatment nivolumab. Using a combination of exome sequencing, transcriptome sequencing, and T-cell receptor sequencing, the researchers characterized tumor and microenvironment features before and after nivolumab treatment in 68 advanced melanoma patients, including 33 individuals who had already progressed on the CTLA-4-targeting drug ipilimumab.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.